Literature DB >> 9893027

Basic pathogenic mechanisms operating in experimental models of acute anterior uveitis.

J R Smith1, P H Hart, K A Williams.   

Abstract

Acute anterior uveitis is a recurrent inflammatory disease of the eye that occurs commonly, is distressing for the patient, and may have potentially blinding sequelae. The pathogenesis of the disease is poorly understood, and anti-inflammatory treatment is consequently non-specific and may be associated with significant complications. Animal models are a possible key to a better understanding of this disease. In one model, rats and mice develop a relatively short-lived anterior uveal inflammation almost immediately after systemic injection of bacterial endotoxin. Accumulating evidence suggests that cytokine production by resident uveal macrophages initiates endotoxin-induced uveitis which is characterized by an infiltration of neutrophils and mononuclear cells. A second model displays features in keeping with a delayed-type hypersensitivity immune response. Experimental melanin-induced uveitis is an acute recurrent uveitis with delayed onset but extended duration, observed when rats are immunized with bovine ocular melanin. Both animal models have clinical features in common with acute anterior uveitis, although experimental melanin-induced uveitis appears to mimic the human disease more closely. Novel treatment options to target implicated inflammatory cells and molecules are currently under consideration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9893027     DOI: 10.1046/j.1440-1711.1998.00783.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  35 in total

Review 1.  Management of sight-threatening uveitis: new therapeutic options.

Authors:  Matthias D Becker; Justine R Smith; Regina Max; Christoph Fiehn
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Immunopathological aspects of age-related macular degeneration.

Authors:  Mrinali Patel; Chi-Chao Chan
Journal:  Semin Immunopathol       Date:  2008-02-26       Impact factor: 9.623

3.  Characterization of microRNA expression profiling in peripheral blood lymphocytes in rats with experimental autoimmune uveitis.

Authors:  Dadong Guo; Jiao Li; Zhengfeng Liu; Kai Tang; Huixin Song; Hongsheng Bi
Journal:  Inflamm Res       Date:  2015-07-08       Impact factor: 4.575

Review 4.  Inflammatory choroidal neovascular membrane in posterior uveitis-pathogenesis and treatment.

Authors:  Narendra Dhingra; Susan Kelly; Mohammed A Majid; Claire B Bailey; Andrew D Dick
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

Review 5.  Uveitis associated with juvenile idiopathic arthritis.

Authors:  Ethan S Sen; Andrew D Dick; Athimalaipet V Ramanan
Journal:  Nat Rev Rheumatol       Date:  2015-03-31       Impact factor: 20.543

6.  Aldose reductase deficiency protects from autoimmune- and endotoxin-induced uveitis in mice.

Authors:  Umesh C S Yadav; Mohammed Shoeb; Satish K Srivastava; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-17       Impact factor: 4.799

Review 7.  Biologic agents in experimental autoimmune uveitis.

Authors:  Gian Paolo Giuliari; Ama Sadaka; David M Hinkle
Journal:  Int Ophthalmol       Date:  2013-03-14       Impact factor: 2.031

8.  Surprising up-regulation of P-selectin glycoprotein ligand-1 (PSGL-1) in endotoxin-induced uveitis.

Authors:  Lama Almulki; Kousuke Noda; Reza Amini; Alexander Schering; Rebecca C Garland; Shintaro Nakao; Toru Nakazawa; Toshio Hisatomi; Kennard L Thomas; Sharmila Masli; Ali Hafezi-Moghadam
Journal:  FASEB J       Date:  2008-12-02       Impact factor: 5.191

9.  Localization of vascular adhesion protein-1 (VAP-1) in the human eye.

Authors:  Lama Almulki; Kousuke Noda; Shintaro Nakao; Toshio Hisatomi; Kennard L Thomas; Ali Hafezi-Moghadam
Journal:  Exp Eye Res       Date:  2009-09-15       Impact factor: 3.467

10.  Susceptibility to endotoxin induced uveitis is not reduced in mice deficient in BLT1, the high affinity leukotriene B4 receptor.

Authors:  J R Smith; K Subbarao; D T Franc; B Haribabu; J T Rosenbaum
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.